Galera Therapeutics, Inc. - Common Stock (NQ:GRTX)

0.1450 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Galera Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology

March 10, 2023

From Galera Therapeutics

Via GlobeNewswire

Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates

March 08, 2023

From Galera Therapeutics

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023 ↗

February 21, 2023

Via Benzinga

Recap: Galera Therapeutics Q2 Earnings ↗

August 09, 2022

Galera Therapeutics (NASDAQ:GRTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 15, 2023

Via Benzinga

Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants

February 15, 2023

From Galera Therapeutics

Via GlobeNewswire

Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis

February 15, 2023

From Galera Therapeutics

Via GlobeNewswire

Galera Therapeutics' Rucosopasem Shows Early Anti-Cancer Activity, Pulmonary Function Preservation ↗

June 29, 2022

Via Benzinga

Galera Therapeutics: Q1 Earnings Insights ↗

May 16, 2022

Galera Therapeutics (NASDAQ:GRTX) reported its Q1 earnings results on Monday, May 16, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Galera Posts Topline Data From Avasopasem Study In Chemoradiotherapy-Induced Esophagitis ↗

May 02, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 16, 2023

Via Benzinga

Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis

December 12, 2022

NDA based on two positive randomized, double-blinded, placebo-controlled trials which enrolled a total of 678 patients

From Galera Therapeutics

Via GlobeNewswire

Galera to Present at Piper Sandler Annual Healthcare Conference

November 22, 2022

From Galera Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 17, 2022

Via Benzinga

Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates

November 09, 2022

From Galera Therapeutics

Via GlobeNewswire

Galera Therapeutics' Avasopasem Reduces Chemo-Related Kidney Disease By 50% Versus Placebo At One-Year ↗

October 26, 2022

Via Benzinga

Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting

October 26, 2022

From Galera Therapeutics

Via GlobeNewswire

Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket ↗

September 26, 2022

Gainers

Via Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 02, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 11, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 14, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 15, 2022

On Friday, 137 stocks made new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 23, 2022

Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the...

Via Benzinga

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗

June 30, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

Galera Therapeutics: Q4 Earnings Insights ↗

March 10, 2022

Galera Therapeutics (NASDAQ:GRTX) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

110 Biggest Movers From Friday ↗

May 16, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Via Benzinga

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation ↗

February 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.